PACIRA PHARMACEUTICALS, INC.

10578 Science Center Dr, San Diego, California, United States

Clinical Trials

110

11 active

Approvals

Total approvals

Agencies

Regulatory bodies

Founded

N/A

Overview

Trial Phase Distribution

Phase

Trials

Phase 2

22.7%

Phase 4

20.9%

Phase 1

20.0%

Phase 3

17.3%

Not Applicable

11.8%

Trial Status Distribution

Active, not recruiting

10.0%

Completed

66.4%

Recruiting

2.7%

Terminated

16.4%

Unknown

0.9%

Withdrawn

3.6%

Clinical Trials

Trials sponsored by this organization (110)

A Study to Evaluate an Intra-Articular Injection of ZILRETTA Versus Triamcinolone Acetonide, Immediate Release in Subjects With Osteoarthritis of the Hip

Phase 2

Terminated

interventional

Jul 20251 participant

A Study to Assess Safety and Tolerability of PCRX-201 in Subjects With Painful Osteoarthritis of the Knee

Phase 2

Recruiting

interventional

Feb 2025135 participants

Study to Assess the Efficacy and Safety of Iovera®° System in Subjects With Upper Extremity Spasticity

Not Applicable

Active, not recruiting

interventional

Jul 2024132 participants

Study to Evaluate the Pharmacokinetics and Safety of EXPAREL for Postoperative Analgesia in Subjects Undergoing Cardiac Surgery

Phase 1

Recruiting

interventional

Mar 202448 participants

ZILRETTA in Subjects With Shoulder Osteoarthritis

Phase 3

Active, not recruiting

interventional

Feb 2024150 participants

Phase 1, Dose Escalation Study to Evaluate of Safety, Pharmacokinetics and Pharmacodynamics of Liposomal Bupivacaine 13.3 Administered Via a Single Intrathecal Injection to Healthy Volunteers

Phase 1

Completed

interventional

Apr 202354 participants

Phase 3, Sciatic Nerve Block With EXPAREL for Subjects Undergoing Bunionectomy

Phase 3

Completed

interventional

Feb 2022185 participants

Phase 3 Adductor Canal Block With EXPAREL in Subjects Undergoing Primary Unilateral Total Knee Arthroplasty

Phase 3

Completed

interventional

Jan 2022167 participants

Page 1 of 14

Approvals

Approvals by Agency

FDA

Food and Drug Administration

Approvals

Recent Approvals

News

No news articles found

Back to Organizations